newsfilter
← Latest News
PR Newswire·

PDL BioPharma Board of Directors Increases Share and Note Repurchase Authorization to $275 Million

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announced today that its Board of Directors has authorized a $75 million increase to the...